Factors that influence emergency department visits for asthma

Canadian Respiratory Journal

Volumn 6, Issue 5, 1999, Pages 429-435

  Tough, S C ^a  

^a Lethbridge Regional Hospital   (Canada)

Author keywords

Asthma; Case control study; Nocturnal asthma; Symptoms; Trigger factors

Indexed keywords

ANTIALLERGIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CROMOGLYCATE DISODIUM; HERBACEOUS AGENT; IPRATROPIUM BROMIDE; KETOTIFEN FUMARATE; STEROID; THEOPHYLLINE;

ADOLESCENT; ADULT; ALLERGY; ARTICLE; ASTHMA; CANADA; CASE CONTROL STUDY; CHILD; CLINICAL TRIAL; CONSULTATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; DRUG USE; EMERGENCY WARD; FEMALE; HOSPITAL ADMISSION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NIGHT; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; STATISTICAL MODEL;

EID: 0032721770     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/1999/743628     Document Type: Article

References (2)

1. Evans R III, Mullally DI, Wilson RW, et al. National trends in the morbidity and mortality of asthma in the US. Chest 1987;91(Suppl 6):65S-74S.
2. Sears MR, Rea HH, Beaglehole R, et al. Asthma mortality in New Zealand; a two year national study. NZ Med J 1985;98:271-5.